BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 28, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 9, 2009
View Archived Issues
Preclinical studies prepare antimalarial GSK-932121 for clinical development
Read More
ARQ-501 synergistic with NU-7026 against metastatic breast cancer cells
Read More
Etifoxine aids peripheral nerve recovery
Read More
Peptide blocking enhancer of NMDAR function suppresses pain hypersensitivity
Read More
Phase I study of ON-1910Na in solid tumor patients identifies phase II dose
Read More
Abbott acquires Isis Pharmaceuticals' subsidiary Ibis Biosciences
Read More
Amira successfully completes toxicity studies for AM-211 and will submit IND in mid-2009
Read More
Onyx acquires option to license rights to S*BIO's JAK2 inhibitors SB-1518 and SB-1578
Read More
Phosphagenics reports results from trial of TPM/insulin in diabetic patients
Read More
MiddleBrook to launch Moxatag in March 2009 for tonsillitis and pharyngitis
Read More
Circassia completes patient recruitment in phase II clinical trial of ToleroMune in cat allergy
Read More
Warner Chilcott and Dong-A sign U.S. license agreement for udenafil in erectile dysfunction
Read More
PPD and Merck & Co. enter into strategic collaboration for vaccine testing
Read More
Preliminary analysis shows no conclusive advantage of oral HMPL-002 in NSCLC
Read More
Peplin presents positive results from phase IIb PEP-005 trial in actinic keratosis
Read More
ANA-598 shows potent antiviral activity in HCV-infected patients
Read More
Crucell and Wyeth are discussing a combination of the two companies
Read More
FDA issues a complete response letter for Lilly's olanzapine in schizophrenia
Read More
Daiichi files application for KMD-3212 in China for dysuria
Read More
Plexxikon and Roche partner to develop PLX-5568 for polycystic kidney disease
Read More
Galderma's Epiduo gel now available in the U.S. to treat acne
Read More
Novel antibody-drug conjugates for the treatment of cancer engineered by scientists at Genentech
Read More
New chemokine CXCR2 receptor antagonists disclosed in recent Novartis patent
Read More
Recent Argenta Discovery patent describes new HNE inhibitors for treatment of respiratory disorders
Read More
Janssen has synthesized novel DGAT-1 inhibitors with potental as antidiabetic agents
Read More
